Yeast Mitochondrial Gln-Trna Is Generated by a Gatfab-Mediated Transamidation Pathway Involving Arc1p-Controlled Subcellular
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Yeast Surface 2-Hybrid to Detect Protein-Protein Interactions Via the Secretory Pathway As a Platform for Antibody Discovery
CORE Metadata, citation and similar papers at core.ac.uk Provided by Nature Precedings Yeast surface 2-hybrid to detect protein-protein interactions via the secretory pathway as a platform for antibody discovery Xuebo Hu1, Sungkwon Kang1, Xiaoyue Chen1, Charles B Shoemaker2, Moonsoo M Jin1 1Department of Biomedical Engineering, Cornell University, Hungerford Hill Road, Ithaca, NY 14853 2Department of Biomedical Sciences, Tufts Cummings School of Veterinary Medicine, 200 Westboro Rd, North Grafton, MA 01536 Correspondence should be addressed to M.M.J. ([email protected]). Abstract: High throughput methods to measure protein-protein interactions will facilitate uncovering pairs of unknown interactions as well as designing new interactions. We have developed a platform to detect protein interactions on the surface of yeast, where one protein (bait) is covalently anchored to the cell wall and the other (prey) is expressed in secretory form. The prey is released either outside of the cells or remains on the cell surface by its binding to the bait. The strength of their interaction is measured by antibody binding to the epitope tag fused to the prey or direct readout of split fluorescence protein complementation. Our novel ‘yeast surface 2-hybrid’ system was found to differentiate 6-log difference in binding affinities between coiled coil associations and to measure specific interactions of antibodies and antigens. We demonstrate the use of YS2H in exploring activation allostery in integrins and isolating heavy chain only antibodies against botulinum neurotoxin. Introduction Protein-protein interactions are essential to virtually every cellular process and their understanding is of great interest in basic science as well as in the development of effective therapeutics. -
WO 2010/129541 Al
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 11 November 2010 (11.11.2010) WO 2010/129541 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every GOlN 33/53 (2006.01) C07K 16/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/US20 10/033537 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 4 May 2010 (04.05.2010) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (26) Publication Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/175,076 4 May 2009 (04.05.2009) US (84) Designated States (unless otherwise indicated, for every 61/305,991 19 February 2010 (19.02.2010) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): AF- ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, FOMIX CORPORATION [US/US]; 688 E. -
Development of Novel Surface Display Platforms for Anchoring
Yang et al. Microb Cell Fact (2019) 18:85 https://doi.org/10.1186/s12934-019-1133-x Microbial Cell Factories RESEARCH Open Access Development of novel surface display platforms for anchoring heterologous proteins in Saccharomyces cerevisiae Xiaoyu Yang1†, Hongting Tang1,3†, Meihui Song1, Yu Shen1, Jin Hou1* and Xiaoming Bao1,2* Abstract Background: Cell surface display of recombinant proteins has become a powerful tool for biotechnology and biomedical applications. As a model eukaryotic microorganism, Saccharomyces cerevisiae is an ideal candidate for surface display of heterologous proteins. However, the frequently used commercial yeast surface display system, the a-agglutinin anchor system, often results in low display efciency. Results: We initially reconstructed the a-agglutinin system by replacing two anchor proteins with one anchor protein. By directly fusing the target protein to the N-terminus of Aga1p and inserting a fexible linker, the display ef- ciency almost doubled, and the activity of reporter protein α-galactosidase increased by 39%. We also developed new surface display systems. Six glycosylphosphatidylinositol (GPI) anchored cell wall proteins were selected to construct the display systems. Among them, Dan4p and Sed1p showed higher display efciency than the a-agglutinin anchor system. Linkers were also inserted to eliminate the efects of GPI fusion on the activity of the target protein. We further used the newly developed Aga1p, Dan4p systems and Sed1p system to display exoglucanase and a relatively large protein β-glucosidase, and found that Aga1p and Dan4p were more suitable for immobilizing large proteins. Conclusion: Our study developed novel efcient yeast surface display systems, that will be attractive tools for bio- technological and biomedical applications Keywords: Yeast surface display, Aga1, Dan4, Sed1, a-Agglutinin, Glycosylphosphatidylinositol (GPI) Background and antibody development, library screening, biosensor Cell surface display expresses a target protein or peptide detection systems, and bioconversion [2]. -
M.Sc. [Botany] 346 13
cover page as mentioned below: below: mentioned Youas arepage instructedcover the to updateupdate to the coverinstructed pageare asYou mentioned below: Increase the font size of the Course Name. Name. 1. IncreaseCourse the theof fontsize sizefont ofthe the CourseIncrease 1. Name. use the following as a header in the Cover Page. Page. Cover 2. the usein the followingheader a as as a headerfollowing the inuse the 2. Cover Page. ALAGAPPAUNIVERSITY UNIVERSITYALAGAPPA [Accredited with ’A+’ Grade by NAAC (CGPA:3.64) in the Third Cycle Cycle Third the in (CGPA:3.64) [AccreditedNAAC by withGrade ’A+’’A+’ Gradewith by NAAC[Accredited (CGPA:3.64) in the Third Cycle and Graded as Category–I University by MHRD-UGC] MHRD-UGC] by University and Category–I Graded as as Graded Category–I and University by MHRD-UGC] M.Sc. [Botany] 003 630 – KARAIKUDIKARAIKUDI – 630 003 346 13 EDUCATION DIRECTORATEDISTANCE OF OF DISTANCEDIRECTORATE EDUCATION BIOLOGICAL TECHNIQUES IN BOTANY I - Semester BOTANY IN TECHNIQUES BIOLOGICAL M.Sc. [Botany] 346 13 cover page as mentioned below: below: mentioned Youas arepage instructedcover the to updateupdate to the coverinstructed pageare asYou mentioned below: Increase the font size of the Course Name. Name. 1. IncreaseCourse the theof fontsize sizefont ofthe the CourseIncrease 1. Name. use the following as a header in the Cover Page. Page. Cover 2. the usein the followingheader a as as a headerfollowing the inuse the 2. Cover Page. ALAGAPPAUNIVERSITY UNIVERSITYALAGAPPA [Accredited with ’A+’ Grade by NAAC (CGPA:3.64) in the Third Cycle Cycle Third the in (CGPA:3.64) [AccreditedNAAC by withGrade ’A+’’A+’ Gradewith by NAAC[Accredited (CGPA:3.64) in the Third Cycle and Graded as Category–I University by MHRD-UGC] MHRD-UGC] by University and Category–I Graded as as Graded Category–I and University by MHRD-UGC] M.Sc. -
Of Lactococcus Garvieae
CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Characterization of Plasmids in a Human Clinical Strain of Lactococcus garvieae Mo´ nica Aguado-Urda1., Alicia Gibello1*., M. Mar Blanco1, Guillermo H. Lo´ pez-Campos2,M. Teresa Cutuli1, Jose´ F. Ferna´ndez-Garayza´bal1,3 1 Faculty of Veterinary Sciences, Department of Animal Health, Complutense University, Madrid, Spain, 2 Bioinformatics and Public Health Department, Health Institute Carlos III, Madrid, Spain, 3 Animal Health Surveillance Center (VISAVET), Complutense University of Madrid, Spain Abstract The present work describes the molecular characterization of five circular plasmids found in the human clinical strain Lactococcus garvieae 21881. The plasmids were designated pGL1-pGL5, with molecular sizes of 4,536 bp, 4,572 bp, 12,948 bp, 14,006 bp and 68,798 bp, respectively. Based on detailed sequence analysis, some of these plasmids appear to be mosaics composed of DNA obtained by modular exchange between different species of lactic acid bacteria. Based on sequence data and the derived presence of certain genes and proteins, the plasmid pGL2 appears to replicate via a rolling- circle mechanism, while the other four plasmids appear to belong to the group of lactococcal theta-type replicons. The plasmids pGL1, pGL2 and pGL5 encode putative proteins related with bacteriocin synthesis and bacteriocin secretion and immunity. The plasmid pGL5 harbors genes (txn, orf5 and orf25) encoding proteins that could be considered putative virulence factors. The gene txn encodes a protein with an enzymatic domain corresponding to the family actin-ADP- ribosyltransferases toxins, which are known to play a key role in pathogenesis of a variety of bacterial pathogens. -
Biological Circuits with Small RNA Switches
Downloaded from genesdev.cshlp.org on September 24, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Stealth regulation: biological circuits with small RNA switches Susan Gottesman Laboratory of Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892, USA So you thinkyou finally understand the regulation of temporal RNAs (stRNAs) or microRNAs, and that these your favorite gene? The transcriptional regulators have RNAs are processed by some of the same protein cofac- been identified; the signaling cascades that regulate syn- tors as is RNAi, have put regulatory RNAs in the spot- thesis and activity of the regulators have been found. light in eukaryotes as well. Recent searches have con- Possibly you have found that the regulator is itself un- firmed that flies, worms, plants, and humans all harbor stable, and that instability is necessary for proper regu- significant numbers of small RNAs likely to play regu- lation. Time to lookfor a new project, or retire and rest latory roles. on your laurels? Not so fast—there’s more. It is rapidly Along with the rapid expansion in RNAs doing inter- becoming apparent that another whole level of regula- esting things, has come a proliferation of nomenclature. tion lurks, unsuspected, in both prokaryotic and eukary- Noncoding RNAs (ncRNA) has been used recently, as otic cells, hidden from our notice in part by the tran- the most general term (Storz 2002). Among the noncod- scription-based approaches that we usually use to study ing RNAs, the subclass of relatively small RNAs that gene regulation, and in part because these regulators are frequently act as regulators have been called stRNAs very small targets for mutagenesis and are not easily (small temporal RNAs, eukaryotes) and sRNAs (small found from genome sequences alone. -
Structural Analysis of Plasmid Pcl2.1 from Lactococcus Lactis Ssp. Lactis ML8 and the Construction of a New Shuttle Vector for Lactic Acid Bacteria
Food Sci. Biotechnol. Vol. 18, No. 2, pp. 396 ~ 401 (2009) ⓒ The Korean Society of Food Science and Technology Structural Analysis of Plasmid pCL2.1 from Lactococcus lactis ssp. lactis ML8 and the Construction of a New Shuttle Vector for Lactic Acid Bacteria Do-Won Jeong1, San Ho Cho, Jong-Hoon Lee2, and Hyong Joo Lee* Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Korea 1Research Institute for Agriculture and Life Sciences, Seoul National University, Seoul 151-921, Korea 2Department of Food Science and Biotechnology, Kyonggi University, Suwon 443-760, Korea Abstract The nucleotide sequence contains 2 open reading frames encoding a 45-amino-acid protein homologous to a transcriptional repressor protein CopG, and a 203-amino-acid protein homologous to a replication protein RepB. Putative countertranscribed RNA, a double-strand origin, and a single-strand origin were also identified. A shuttle vector, pUCL2.1, for various lactic acid bacteria (LAB) was constructed on the basis of the pCL2.1 replicon, into which an erythromycin-resistance gene as a marker and Escherichia coli ColE1 replication origin were inserted. pUCL2.1 was introduced into E. coli, Lc. lactis, Lactobacillus (Lb.) plantarum, Lb. paraplantarum, and Leuconostoc mesenteroides. The recombinant LAB maintained traits of transformed plasmid in the absence of selection pressure over 40 generations. Therefore, pUCL2.1 could be used as an E. coli/LAB shuttle vector, which is an essential to engineer recombinant LAB strains that are useful for food fermentations. Keywords: pCL2.1, shuttle vector, lactic acid bacteria Introduction such as involving simpler manipulations and efficient gene introduction into LAB. -
Tetracycline-Resistance Encoding Plasmids from Paenibacillus Larvae, the Causal Agent of American Foulbrood Disease, Isolated from Commercial Honeys
RESEARCH ARTICLE International Microbiology (2014) 17:49-61 doi:10.2436/20.1501.01.207 ISSN (print): 1139-6709. e-ISSN: 1618-1095 www.im.microbios.org Tetracycline-resistance encoding plasmids from Paenibacillus larvae, the causal agent of American foulbrood disease, isolated from commercial honeys Adriana M. Alippi,* Ignacio E. León, Ana C. López Bacteriology Unit, Phytopathology Research Center, Faculty of Agricultural and Forestry Sciences, National University of La Plata, La Plata, Argentina Received 5 January 2014 · Accepted 25 March 2014 Summary. Paenibacillus larvae, the causal agent of American foulbrood disease in honeybees, acquires tetracycline-resis- tance via native plasmids carrying known tetracycline-resistance determinants. From three P. larvae tetracycline-resistant strains isolated from honeys, 5-kb-circular plasmids with almost identical sequences, designated pPL373 in strain PL373, pPL374 in strain PL374, and pPL395 in strain PL395, were isolated. These plasmids were highly similar (99%) to small tetra- cycline-encoding plasmids (pMA67, pBHS24, pBSDMV46A, pDMV2, pSU1, pAST4, and pLS55) that replicate by the rolling circle mechanism. Nucleotide sequences comparisons showed that pPL373, pPL374, and pPL395 mainly differed from the previously reported P. larvae plasmid pMA67 in the oriT region and mob genes. These differences suggest alternative mobili- zation and/or conjugation capacities. Plasmids pPL373, pPL374, and pPL395 were individually transferred by electroporation and stably maintained in tetracycline-susceptible P. larvae NRRL B-14154, in which they autonomously replicated. The presence of nearly identical plasmids in five different genera of gram-positive bacteria, i.e., Bhargavaea, Bacillus, Lactoba cillus, Paenibacillus, and Sporosarcina, inhabiting diverse ecological niches provides further evidence of the genetic transfer of tetracycline resistance among environmental bacteria from soils, food, and marine habitats and from pathogenic bacteria such as P. -
Title Evaluation of the Yeast Surface Display System For
Evaluation of the yeast surface display system for screening of Title functional nanobodies Author(s) Kajiwara, Kaho; Aoki, Wataru; Ueda, Mitsuyoshi Citation AMB Express (2020), 10 Issue Date 2020-03-16 URL http://hdl.handle.net/2433/250108 © The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included Right in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Type Journal Article Textversion publisher Kyoto University Kajiwara et al. AMB Expr (2020) 10:51 https://doi.org/10.1186/s13568-020-00983-y ORIGINAL ARTICLE Open Access Evaluation of the yeast surface display system for screening of functional nanobodies Kaho Kajiwara1, Wataru Aoki1,2 and Mitsuyoshi Ueda1,2* Abstract Yeast surface display is a powerful technology used to isolate and engineer proteins to improve their activity, specifc- ity, and stability. In this method, gene expression is regulated by promoters, and secretion efciency is afected by secretion signals. -
Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands
International Journal of Molecular Sciences Article Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands John Bowen 1, John Schneible 1 , Kaitlyn Bacon 1, Collin Labar 2, Stefano Menegatti 1,3,* and Balaji M. Rao 1,3,* 1 Department of Chemical and Biomolecular Engineering, North Carolina State University, 911 Partners Way, Raleigh, NC 27695, USA; [email protected] (J.B.); [email protected] (J.S.); [email protected] (K.B.) 2 Department of Molecular and Structural Biochemistry, North Carolina State University, Raleigh, NC 27695, USA; [email protected] 3 Biomanufacturing Training and Education Center (BTEC), North Carolina State University, 850 Oval Dr, Raleigh, NC 27606, USA * Correspondence: [email protected] (S.M.); [email protected] (B.M.R.) Abstract: We present the construction and screening of yeast display libraries of post-translationally modified peptides wherein site-selective enzymatic treatment of linear peptides is achieved using bacterial transglutaminase. To this end, we developed two alternative routes, namely (i) yeast display of linear peptides followed by treatment with recombinant transglutaminase in solution; or (ii) intracellular co-expression of linear peptides and transglutaminase to achieve peptide modification in the endoplasmic reticulum prior to yeast surface display. The efficiency of peptide modification was evaluated via orthogonal detection of epitope tags integrated in the yeast-displayed peptides by flow cytometry, and via comparative cleavage of putative cyclic vs. linear peptides by tobacco etch virus (TEV) protease. Subsequently, yeast display libraries of transglutaminase-treated peptides were screened to isolate binders to the N-terminal region of the Yes-Associated Protein (YAP) and its WW domains using magnetic selection and fluorescence activated cell sorting (FACS). -
Phage and Yeast Display of Antibodies and Proteins
Register EARLY and SAVE! the sheraton boston hotel boston TWELFTH ANNUAL Phage and Yeast Display of Antibodies and Proteins May 17 - 18, 2010 DESIGN proteins and novel scaffolds with drug-like properties and IMPACT the biologics PIPELINE DISTINGUISHED FacUlty KEYNOTE PRESENTATIONS Phage Display Traps for Protein Conformation and Jennifer Cochran, Ph.D., Stanford Medical Center Specific Composition Daniel Christ, Ph.D., Garvan Institute of Medical Research James A. Wells, Ph.D., Department of Pharmaceutical and The University of New South Wales Chemistry, University of California, San Francisco Stephen J. Demarest, Ph.D., Biogen IDEC Inc. Michael J. Feldhaus, Ph.D., Adimab Inc. Research and Development of Next-Generation of Antibody-Based Therapeutics: Challenges and Nicolas Fischer, Ph.D., NovImmune SA Opportunities Prof. Christian Heinis, Ph.D., Ecole Polytechnique Federal Zhenping Zhu, M.D., Ph.D., Vice President and Global de Lausanne (EPFL) Head, Protein Sciences & Design, Novartis Biologics David King, Ph.D., Anaptys Bio Joost Kolkman, Ph.D., Ablynx Next-Generation Biologics Albert Einstein College of Medicine Herren Wu, Ph.D., Vice President, Antibody Discovery & Jonathan R. Lai, Ph.D., Protein Engineering, MedImmune Peter Luo, Ph.D., Merck & Co., Inc. and Abmaxis, Inc. Jaume Pons, Ph.D., Rinat Pfizer Balaji Rao, Ph.D., North Carolina State Eric V. Shusta, Ph.D., University of Wisconsin Madison RECOMMENDED SHORT COURSES Danica Stanimirovic, M.D., Ph.D., National Research (SC1) Phage and Yeast Display Libraries and Council, Canada their Screening John Wheeler, Ph.D., Centocor Lonza Biologics plc (SC7) Phage Display for Vaccine Development Jesús Zurdo, Ph.D., Corporate Sponsors Corporate Support Sponsor MedImmune Part of: Sixth Annual Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, Massachusetts 02494 Telephone: 781-972-5400 PEGS Toll-free in the U.S. -
Yeast Display-Based Antibody Discovery and Optimization Technologies Avantgen Company Overview
Advantageous Technologies, Exceptional Results Yeast Display-Based Antibody Discovery and Optimization Technologies AvantGen Company Overview • Services and Collaborations – San Diego-based leader in providing antibody discovery and optimization services based on its state-of-the-art yeast display technology platform • Rapid discovery of human antibodies • Exceptional antibody humanization and optimization • Rabbit mAb generation for IHC and PK/PD studies • Core technologies – Superior antibody yeast display platform • Proprietary, inducible, secretable display motif – Comprehensive human antibody database – Large collection of human antibody libraries • Team – Proven expert R&D and business leaders in therapeutic antibodies 2 Yeast Display is a Superior Platform • Widely recognized as a preferred technology platform for rapidly discovering and optimizing mAbs of exceptional quality for therapeutic development • Can also be used to optimize and humanize antibodies originating from in vivo immunization or in vitro phage display approaches 3 Core Platform Technology Advantages Comparison of in vitro Antibody Discovery and Optimization Platforms Features Phage Display Yeast Display Antibody Format Limited Extensive Display Diversified Limited/Biased Excellent Libraries ¹ Developability Low High ¹ Yeast System Provides Improved Display of Diversity Across Diverse Human Antibody V Families vs. Phage Phage Display Yeast Display 4 Core Platform Exceptional Human Antibody Libraries • Constructed to mimic natural sequence variation in human antibodies